Alyeska Investment Group, L.P. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 215 filers reported holding NEVRO CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of NEVRO CORP
ValueSharesWeighting
Q4 2021$22,294,000
-36.1%
275,000
-8.3%
0.26%
-40.5%
Q3 2021$34,914,000
+6745.9%
300,000
+8107.9%
0.43%
+6071.4%
Q1 2021$510,000
-74.9%
3,655
-68.9%
0.01%
-75.9%
Q4 2020$2,035,000
-85.6%
11,755
-90.1%
0.03%
-86.5%
Q2 2020$14,156,000
-34.3%
118,491
-56.1%
0.22%
+11.4%
Q2 2018$21,545,000
+734.4%
269,816
+621.4%
0.19%
+819.0%
Q4 2017$2,582,000
+181.0%
37,400
+324.6%
0.02%
+133.3%
Q3 2016$919,000
-69.9%
8,808
-78.7%
0.01%
-69.0%
Q2 2016$3,051,000
+56.6%
41,367
+19.5%
0.03%
+61.1%
Q1 2016$1,948,00034,6170.02%
Other shareholders
NEVRO CORP shareholders Q4 2021
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders